BRIEF-Peregrine Pharma up in premarket after announcing progress in advancing Cotara program

NEW YORK Wed Dec 5, 2012 8:54am EST

NEW YORK Dec 5 (Reuters) - Peregrine Pharmaceuticals Inc : * Peregrine Pharma up 20.2 percent to $1.55 in premarket after company announces progress in advancing its Cotara program into a phase III trial

FILED UNDER: